Reduction in both islet glucagon and GLP-1 led to impaired glucose tolerance when challenged with an IPGTT (Fig. 5F), manifested by reduced insulin secretion both in vivo (Fig. 5G) and in perifused ex vivo islets (Fig. 5H). Here, INS is linked to Impaired glucose tolerance.